Definitive chemoradiotherapy
Original Article Recombinant human endostatin combined with definitive chemoradiotherapy for patients with locally advanced esophageal carcinoma
... Abstract: Background: The efficacy and toxicity of recombinant human endostatin combined with docetaxel, cispla- tin, and radiation therapies were evaluated in patients with locally advanced esophageal cancer. Methods: ...
8
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
... node (mLN) to definitive chemoradiotherapy (dCRT) and guide personalized radiation dose in esophageal squamous cell carcinoma (ESCC) patients.. Patients and methods: One hundred and fo[r] ...
9
The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
... dCRT: Definitive chemoradiotherapy; EAC: Esophageal adenocarcinoma; ESCC: Esophageal squamous cell carcinoma; LCAF: Late course accelerated fractionation; nRCT: Non-randomised clinical trial; OR: Odds ...
10
Id1 and Id3 co expression correlates with clinical outcome in stage III N2 non small cell lung cancer patients treated with definitive chemoradiotherapy
... Results: Id1 expression is observed in 82.4% of the tumors, whereas Id3 expression is present in 41.2% of the samples. Interestingly, Id1 and Id3 expression are mutually correlated (R = 0.579, p = 0.015). In a subgroup ...
8
The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
... Background: The lymphocyte–monocyte ratio (LMR), a simple biomarker that can reflect the antitumor immune response of the host, has been associated with patient prognosis in several solid tumors. The aim of this study ...
7
Original Article Comparison of larynx-preserving esophagectomy and definitive chemoradiotherapy for patients with cervical esophageal squamous cell carcinoma
... In this study, 50 patients received larynx-pre- serving esophagectomy for cervical ESCC. The 5-year overall survival rate, the complication rate and the mortality rates were 44.2%, 24% and 2%, respectively, which were ...
8
<p>Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer</p>
... a subgroup of patients who has locoregional “ oligo- recurrence ” characterized by restricted tumor metastatic capacity and limited total tumor burden, and who respond well to chemoradiotherapy. Our data con fi ...
9
Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: Experience from a single institution
... After obtaining institutional review board approval, we retrospectively reviewed a total of 5 patients who under- went surgical treatment for pulmonary metastases from esophageal carcinoma at the Shizuoka Cancer Center, ...
6
<p>Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes</p>
... CRT, chemoradiotherapy; CT, computed tomogra- phy; CTV, clinical target volume; DFFS, distant failure-free survival; ECOG, Eastern Cooperative Oncology Group; ESCC, esophageal squamous cell carcinomas; ESMO, ...
9
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
... In RTOG 0522, a trial designed to test the benefits for the addition of cetuximab to chemoradiotherapy in squamous cell head and neck cancer, patients receiving cetuximab experienced mor[r] ...
8
Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
... Background and aim: To evaluate the impact of percutaneous endoscopic gastrostomy (PEG) tube on nutritional status, treatment-related toxicity, and treatment tolerance in patients with locally advanced nasopharyngeal ...
7
Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
... the DP regimen led to a better overall response rate and OS compared to PF (median OS: 43.2 vs. 22.3 months, P < 0.05). In contrast, another retrospective study reported by Adelstein et al. suggested that a ...
9
Click here to download PDF version of the article !
... Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy: ADC Response in Cervical Carcinoma.. Ti[r] ...
6
Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review
... Radiation therapy is fully integrated in multimodality therapy for all stages of lung cancer, regardless of the applica- tion of definitive or palliative therapy. It is estimated that 50% of all patients with ...
9
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
... We feel that our findings are compatible with the prevalent concept that esophagectomy is an integral part of treatment for locally advanced esophageal cancer [1], possibly through improved disease control (demon- ...
8
Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non small cell lung cancer: a meta analysis
... neoadjuvant chemoradiotherapy has also been developed, thereby establishing a need to test whether chemoradiother- apy is more beneficial than induction chemotherapy ...
10
Download Download PDF
... Cervical esophageal cancer (CEC) is uncommon, accounting for less than 5% of all esophageal cancers. The management of CEC is controversial. This study investigated treatment outcomes and prognostic factors of survival ...
9
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
... Supplementary Material Appendix 1: Trial design Inclusion in trial prior to chemoradiotherapy High dose chemoradiotherapy Evaluation 6 weeks after the end of treatment Clinical examinati[r] ...
7
Comparative analysis of concurrent and sequential chemoradiation in locally advanced lung cancer: a single institution experience
... sequential chemoradiotherapy and concurrent chemoradiotherapy were formed and compared for ...sequential chemoradiotherapy group, the median survival time was ...concurrent chemoradiotherapy ...
5
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up to date meta analysis
... Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection an up to date meta analysis REVIEW Open Access Postoperative chemoradiotherapy versus c[.] ...
9